Miles Nunn

Chief Scientific Officer at Akari Therapeutics - New York, NY, US

Miles Nunn's Contact Details
HQ
929-274-7510
Location
Company
Akari Therapeutics
Miles Nunn's Company Details
Akari Therapeutics logo, Akari Therapeutics contact details

Akari Therapeutics

New York, NY, US • 20 - 49 Employees
BioTech/Drugs

Akari is a biopharmaceutical company focused on developing inhibitors of acute and chronic inflammation, specifically for the treatment of rare and orphan diseases, in particular those where the complement (C5) or leukotriene (LTB4) systems, or both complement and leukotrienes together, play a primary role in disease progression. Akari's lead drug candidate, nomacopan (formerly known as Coversin), is a C5 complement inhibitor that also independently and specifically inhibits leukotriene B4 (LTB4) activity.

Biotechnology Healthcare Pharmaceuticals
Details about Akari Therapeutics
Frequently Asked Questions about Miles Nunn
Miles Nunn currently works for Akari Therapeutics PLC.
Miles Nunn's role at Akari Therapeutics PLC is Chief Scientific Officer.
Miles Nunn's email address is ***@akaritx.com. To view Miles Nunn's full email address, please signup to ConnectPlex.
Miles Nunn works in the Biotechnology industry.
Miles Nunn's colleagues at Akari Therapeutics are Philip Stromeyer, Malakeh Mouh, Nekane Aspe, Naresh Sabharwal, James Fettiplace, Torsten Hombeck, Professor Tim and others.
Miles Nunn's phone number is 929-274-7510
See more information about Miles Nunn